The identification of Amyloid-β oligomers (AβO), which are believed to be responsible for the neurotoxic effects associated with Alzheimer’s disease, was specifically accomplished by utilizing cellular prion protein (PrPC) as a biometric component. The gene discussed is PRNP; the disease is early-onset autosomal dominant Alzheimer disease.